Systemic—pulmonary shunt with a right retroesophageal subclavian artery

1995 ◽  
Vol 59 (2) ◽  
pp. 520-522 ◽  
Author(s):  
Benoit Legault ◽  
Lionel Camilleri ◽  
Patrick Bailly ◽  
Isabelle Brazzalotto ◽  
Jean-René Lusson ◽  
...  
2002 ◽  
Vol 16 (3) ◽  
pp. 387-390 ◽  
Author(s):  
Norbert Boas ◽  
Frederic Desmoucelle ◽  
Vincent Bernadet ◽  
Jean-Claude Franceschi

2000 ◽  
Vol 69 (3) ◽  
pp. 940-942 ◽  
Author(s):  
Makoto Takeda ◽  
Akira Furuse ◽  
Shinichi Takamoto

2006 ◽  
Vol 131 (5) ◽  
pp. 1183-1184.e1 ◽  
Author(s):  
Frédéric Vanden Eynden ◽  
Jacques Devière ◽  
Marc Laureys ◽  
Didier de Cannière

2003 ◽  
Vol 18 (suppl 5) ◽  
pp. 54-56 ◽  
Author(s):  
Valéria Paula Sassoli Fazan ◽  
Rogério Alves Ribeiro ◽  
João Alberto S. Ribeiro ◽  
Omar Andrade Rodrigues Filho

PURPOSE: The subclavian arteries can vary on their origin, course or length. One of the most common anatomical variations is the right subclavian artery originating as the last branch of the aortic arch. This artery is known as a retroesophageal right subclavian artery or "lusory artery". The right retroesophageal subclavian artery usually is described as not producing symptoms, being most discoveries coincidental. Nevertheless, it may be the site of formation of atherosclerotic plaque, inflammatory lesions or aneurysm. CASE REPORT: The present study describes a case of right retroesophageal subclavian artery and discusses the findings according to their clinical and surgical implications. CONCLUSION: The anatomic and morphologic variations of the aortic arch and its branches are significant for diagnostic and surgical procedures in the thorax and neck. If a right retroesophageal subclavian artery is diagnosed during aortic arch repair, corrective surgery should be considered. Intensive care patients should be screened before long term placement of nasogastic tube, in order to avoid fistulization and fatal hemorrhage.


2014 ◽  
Vol 26 (1) ◽  
pp. 49-52
Author(s):  
Mohamed Bouayad ◽  
Salwa Oussama ◽  
Brahim Lekehal ◽  
Samir Elkhloufi ◽  
Redouane Elidrissi ◽  
...  

2015 ◽  
Vol 3 (10) ◽  
pp. 897-898 ◽  
Author(s):  
Ian Reynolds ◽  
James McGarry ◽  
Hannan Mullett

2001 ◽  
Vol 15 (6) ◽  
pp. 699-702 ◽  
Author(s):  
Florent Sala ◽  
Pierre Jean Bouillane ◽  
Marc Paul Francisci ◽  
Fernando Diaz ◽  
Pierre Lena ◽  
...  

1994 ◽  
Vol 33 (05) ◽  
pp. 206-214 ◽  
Author(s):  
J. Triller ◽  
H. U. Baer ◽  
Livia Geiger ◽  
H. F. Beer ◽  
C. Becker ◽  
...  

SummaryTwenty patients with unresectable hepatocellular carcinoma (HCC) were followed up to 5 years after transarterial radiotherapy with 90Y-resin particles. Diagnostic radioembolizations of 99mTc-macroaggregates facilitated scintigraphic assessment of activity distribution, dose evaluation and final procedural verification. The overall survival rates were 56, 38 and 14% (after 1, 2 and 3 years, resp.). Patients with unifocal HCC and a single feeding artery (n = 7) even presented 83, 67 and 40% (2 alive after 2.75 and 4 years). With multiple arteries (n = 7), the longest survival was 26 months. Patients with multifocal HCC survived up to 33 months after selective radioembolization. Quality of life was improved in all. Survival was positively correlated with absorbed dose but residual/recurrent tumour occurred even after ≥300 Gy. Post-treatment symptoms were minimal (35 applications), pulmonary shunt rates were correctly predicted and pulmonary complications avoided.


Sign in / Sign up

Export Citation Format

Share Document